NHS selects Advanced Input hypoallergenic keyboards

TriMed Staff | | Health Imaging | Practice Management
The Connecting for Health Agency within the U.K. National Health Service (NHS) has purchased 7,500 Medigenic infection resistant keyboards from Advanced Input Systems, for use in English hospitals to help improve patient safety by preventing the spread of hospital infections.

Originally developed for University College London Hospital (UCLH) in London in a pilot project supported by NHS, the keyboards incorporate a flashing light to remind users to regularly clean the surface and sensors to measure the effectiveness of cleaning them, according to the Coeur d’Alene, Idaho-based company.

Advanced Input said its new completely flat keyboards are covered with a hypoallergenic material resistant to bacterial growth.

TriMed Staff

Related Content

Clinicians want AI to show its work
Multidose contrast injectors could increase waste in some radiology departments
Imaging leaders share 7 key considerations for remote scanning programs
Policies and regulations shaping radiology in 2025
Can large language models break language barriers in radiology reports?
Most patients want to know if AI is involved in their care

Around the web

Radiology Business
The biggest obstacles facing radiology business managers in 2025

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.

Cardiovascular Business
New cardiac prevention paradigm explored in TRANSFORM trial using AI and CCTA

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.

Cardiovascular Business
Cardiology practices pay $17.7M to settle fraud allegations brought on by whistleblowers

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.